Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 1/2 1

Status

Completed 4

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 3Head & Neck 1Gynecologic 1Genitourinary 1

Conditions

Colorectal Neoplasms 2Urinary Bladder Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Recurrent Platinum Resistant Ovarian Cancer 1Rectal Neoplasms 1Neoplasm Metastasis 1Carcinoma 1Adenoviridae Infections 1

Interventions

Cisplatin 3202Cyclophosphamide 3195Carboplatin 2977Radiotherapy 2790Paclitaxel 2718Gemcitabine 2572pembrolizumab 2385Bevacizumab 2209Docetaxel 2199Fluorouracil 1851Capecitabine 1833Oxaliplatin 1742Dexamethasone 1605Nivolumab 1581Doxorubicin 1501Rituximab 1488Magnetic Resonance Spectroscopy 1387Etoposide 1346Irinotecan 1248Leucovorin 1226Drug Therapy 1205Cytarabine 1130Pemetrexed 1076fludarabine 1063Specimen Handling 1017Vincristine 964Cetuximab 945Trastuzumab 945Prednisone 942Lenalidomide 937

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
enadenotucirev × Clear all
NCT03916510 2025-02-06

CEDAR

University of Oxford

Phase 1 Completed
12 enrolled 13 charts
Gastrointestinal

Adenoviridae Infections, Rectal Neoplasms

NCT02636036 2021-11-09

SPICE

Akamis Bio

Phase 1 Completed
51 enrolled
GastrointestinalHead & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Neoplasm Metastasis, Colorectal Neoplasms

NCT02028117 2021-05-13

OCTAVE

Akamis Bio

Phase 1 Completed
38 enrolled
Gynecologic

Recurrent Platinum Resistant Ovarian Cancer

NCT02028442 2020-03-12

EVOLVE

Akamis Bio

Phase 1/2 Completed
61 enrolled
GastrointestinalGenitourinary

Urinary Bladder Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡